Document Detail

Acid suppression does not reduce symptoms from vocal cord dysfunction, where gastro-laryngeal reflux is a known trigger.
MedLine Citation:
PMID:  23347153     Owner:  NLM     Status:  Publisher    
Vocal cord dysfunction (VCD) is characterised by paradoxical inspiratory abduction of the vocal cords. Gastro-oesophageal reflux disease (GORD) is a known trigger. We studied 77 patients referred to a tertiary VCD clinic. VCD was diagnosed in 62 patients. 83.9% of this group had proven GORD. Following 8 weeks of acid suppression 24.2% reported improvement in the severity and frequency of VCD attacks. This study suggests that empirical treatment of GORD in VCD marginally improves symptom control.
Kerry Woolnough; John Blakey; Nicola Pargeter; Adel Mansur
Related Documents :
1809443 - The role of litigation in predicting disability outcomes in chronic pain patients.
24684603 - Transcutaneous vagus nerve stimulation for refractory epilepsy: a randomized controlled...
20038763 - Emerging multiple sclerosis oral therapies.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-25
Journal Detail:
Title:  Respirology (Carlton, Vic.)     Volume:  -     ISSN:  1440-1843     ISO Abbreviation:  Respirology     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9616368     Medline TA:  Respirology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2013 The Authors. Respirology © 2013 Asian Pacific Society of Respirology.
Birmingham Heartlands Hospital, Respiratory Medicine, Bordesley Green East, Birmingham, B9 5SS, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical Implications of Periostin in the Liver Metastasis of Colorectal Cancer.
Next Document:  Klebsiella pneumoniae targets an EGF receptor-dependent pathway to subvert inflammation.